Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 410.52% is 8735% above its 5-year average of 4.65%, near the high end of its 5-year range (3.87%–410.52%).
7910.15% above its 12-month average of 5.13%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
410.52%
RETURN ON ASSETS (ROA) AVG TTM
5.13%
RETURN ON ASSETS (ROA) AVG 3Y
4.62%
RETURN ON ASSETS (ROA) AVG 5Y
4.65%
RETURN ON ASSETS (ROA) AVG 10Y
4.48%
RETURN ON ASSETS (ROA) AVG 15Y
4.61%
RETURN ON ASSETS (ROA) AVG 20Y
7.07%
CURRENT VS TTM AVG
+7910.15%
CURRENT VS 3Y AVG
+8790.53%
CURRENT VS 5Y AVG
+8734.72%
CURRENT VS 10Y AVG
+9057.82%
CURRENT VS 15Y AVG
+8809.45%
CURRENT VS 20Y AVG
+5704.16%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+7886.77%
vs the sector median at left
Medtronic plc
Market Cap
$118.26B
Return on Assets (ROA)
410.52%
TTM Avg
5.13%
3Y Avg
4.62%
5Y Avg
4.65%
Market Cap
$122.58B
Return on Assets (ROA)
1.93%
TTM Avg
1.25%
3Y Avg
1.93%
5Y Avg
2.38%
Market Cap
$123.70B
Return on Assets (ROA)
15.04%
TTM Avg
13.09%
3Y Avg
12.00%
5Y Avg
11.68%
Market Cap
$105.97B
Return on Assets (ROA)
7.78%
TTM Avg
6.88%
3Y Avg
7.02%
5Y Avg
6.41%
Market Cap
$132.14B
Return on Assets (ROA)
10.59%
TTM Avg
-0.92%
3Y Avg
3.28%
5Y Avg
1.99%
Market Cap
$104.10B
Return on Assets (ROA)
5.20%
TTM Avg
5.08%
3Y Avg
5.08%
5Y Avg
2.52%
Market Cap
$134.24B
Return on Assets (ROA)
16.06%
TTM Avg
6.37%
3Y Avg
11.74%
5Y Avg
14.58%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medtronic plc (MDT) | $118.26B | 410.52% | 5.13% | 4.62% | 4.65% |
| CVS Health Corp. (CVS)vs › | $122.58B | 1.93% | 1.25% | 1.93% | 2.38% |
| Intuitive Surgical, Inc. (ISRG)vs › | $123.70B | 15.04% | 13.09% | 12.00% | 11.68% |
| Stryker Corporation (SYK)vs › | $105.97B | 7.78% | 6.88% | 7.02% | 6.41% |
| Bristol-Myers Squibb Company (BMY)vs › | $132.14B | 10.59% | -0.92% | 3.28% | 1.99% |
| McKesson Corporation (MCK)vs › | $104.10B | 5.20% | 5.08% | 5.08% | 2.52% |
| Sanofi (SNY)vs › | $103.62B | 3.12% | 5.18% | 5.31% | 6.19% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $134.24B | 16.06% | 6.37% | 11.74% | 14.58% |
| GSK plc (GSK)vs › | $97.25B | 7.91% | 6.85% | 11.28% | 9.07% |
| Danaher Corporation (DHR)vs › | $144.25B | 4.33% | 4.68% | 5.89% | 6.01% |
ROA
410.5%
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-04-24 | 5.16% |
| 2025-04-25 | 5.09% |
| 2024-04-26 | 4.09% |
| 2023-04-28 | 4.13% |
| 2022-04-29 | 5.54% |
| 2021-04-30 | 3.87% |
| 2020-04-24 | 5.28% |
| 2019-04-26 | 5.16% |
| 2018-04-27 | 3.40% |
| 2017-04-28 | 4.04% |
| 2016-04-29 | 3.55% |
| 2015-04-24 | 2.51% |
| 2014-04-30 | 8.08% |
| 2013-04-30 | 9.96% |
| 2012-04-30 | 10.93% |
| 2011-04-30 | 10.18% |
| 2010-04-30 | 11.03% |
| 2009-04-30 | 9.17% |
| 2008-04-30 | 10.05% |
| 2007-04-30 | 14.36% |
| 2006-04-30 | 12.95% |
| 2005-04-30 | 10.86% |
| 2004-04-30 | 13.89% |
| 2003-04-30 | 12.98% |
| 2002-04-30 | 9.02% |
| 2001-04-30 | 14.86% |
| 2000-04-30 | 19.38% |
| 1999-04-30 | 9.62% |
| 1998-04-30 | 21.43% |
| 1997-04-30 | 24.21% |
